Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobetasol propionate versus placebo for erosive oral lichen planus
ISRCTN10647973Phase 3Completed
- Sponsor
- University of Turin
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in oral lichen planus (OLP) comparing Clobetasol propionate arm with Placebo arm (2 arms). Primary endpoints: Pain and Clinical lesion severity. Started Jan 2016; status: completed.
02
Drugs
clobetasol
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on ISRCTN10647973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10647973.